Lobbying ≠ campaign money. These LDA lobbying figures are a separate, unbridged channel from FEC campaign contributions; this platform does not yet link a lobbying registrant to any FEC committee. See the methodology glossary.
THE MCMANUS GROUP
Lobbying registrant · 286096
52 filings on record; a reported $2,640,000 in total across them. Honesty note: each amount is the registrant's reported lobbying income/spend for that quarter (a lump sum required by the Lobbying Disclosure Act, or LDA — the law governing public lobbying reports), so this total is a gross sum of quarterly figures. The filings do disclose which bills were lobbied on (below), but never how much of the money went to any one bill, and never whether the filer supported or opposed it.
Clients
- ZIMMER BIOMET
- WEX HEALTH
- VIVEX BIOLOGICS
- VIALASE INC.
- VENTURE MEDICAL
- ROCHE DIAGNOSTICS
- PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
- OWLET
- NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC)
- MEDICAL DEVICE MANUFACTURERS ASSOCIATION
- LARGE UROLOGY GROUP PRACTICE ASSOCIATION
- INFUSION PROVIDERS ALLIANCE
- GRAIL, INC.
- GILEAD SCIENCES, INC.
- GENENTECH
- FULCRUM THERAPEUTICS
- DENDREON PHARMACEUTICALS LLC
- BRISTOL-MYERS SQUIBB
- BIOWOUND SOLUTIONS
- AMBULATORY SURGERY CENTER ASSOCIATION
- AMERICAN OCCUPATIONAL THERAPY ASSOCIATION
- ARDELYX
- AMGEN
- ACESSO BIOLOGICS
- MEDICARE ALLIANCE FOR BENEFICIARY ACCESS (MABA)
- ROYAL BIOLOGICS
- SIGHT SCIENCES
Filings
Source: Senate LDA filings.
Bills lobbied on
Bills named in this registrant's filings. A titled link means the bill is in our corpus; a bare canonical reference means it is not.
- us-119-hr-1157 (not in corpus)
- us-119-hr-1262 (not in corpus)
- us-119-hr-1492 (not in corpus)
- us-119-hr-1614 (not in corpus)
- us-119-hr-1796 (not in corpus)
- us-119-hr-2013 (not in corpus)
- BO’s Act (us-119-hr-2168)
- us-119-hr-2474 (not in corpus)
- us-119-hr-2484 (not in corpus)
- us-119-hr-3006 (not in corpus)
- us-119-hr-3134 (not in corpus)
- us-119-hr-4037 (not in corpus)
- CONNECT for Health Act of 2025 (us-119-hr-4206)
- Protecting Patient Access to Cancer and Complex Therapies Act (us-119-hr-4299)
- us-119-hr-4710 (not in corpus)
- RESULTS Act (us-119-hr-5269)
- Ensuring Patient Access to Critical Breakthrough Products Act (us-119-hr-5343)
- Choice Arrangement (us-119-hr-5463)
- us-119-hr-548 (not in corpus)
- us-119-hr-5582 (not in corpus)
- us-119-hr-5768 (not in corpus)
- us-119-hr-6214 (not in corpus)
- us-119-hr-6852 (not in corpus)
- Outpatient Surgery Access Act of 2026 (us-119-hr-8091)
- Provider Reimbursement Stability Act of 2026 (us-119-hr-8163)
- SECURE Data Act (us-119-hr-8413)
- us-119-hr-842 (not in corpus)
- us-119-hr-879 (not in corpus)
- Chronic Disease Flexible Coverage Act (us-119-hr-919)
- Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 (us-119-hr-9260)
- us-119-hr-9393 (not in corpus)
- Tax Exempt Hospital Transparency Act (us-119-hr-9504)
- us-119-s-1261 (not in corpus)
- us-119-s-1629 (not in corpus)
- us-119-s-1640 (not in corpus)
- us-119-s-1717 (not in corpus)
- us-119-s-1776 (not in corpus)
- Patients Deserve Price Tags Act (us-119-s-2355)
- us-119-s-2420 (not in corpus)
- us-119-s-2561 (not in corpus)
- us-119-s-2847 (not in corpus)
- us-119-s-2875 (not in corpus)
- us-119-s-3345 (not in corpus)
- us-119-s-339 (not in corpus)
- us-119-s-3712 (not in corpus)
- us-119-s-735 (not in corpus)
- us-119-s-832 (not in corpus)
- us-119-s-932 (not in corpus)
Bill references are free-text extractions from LDA specific_issues;
they show a bill was named in a quarter, not money spent on it.